捷利交易寶(08017.HK)正設法增強區塊鏈交易所交易系統平台功能
格隆匯10月29日丨捷利交易寶(08017.HK)公告,集團於2018年9月與現有客户訂立合約,以開發區塊鏈交易所交易系統平台。該系統已於2018年11月完成並交付使用。於2019年10月,集團與客户簽訂了補充協議以增強系統的某些功能,集團預計將於2019年11月完成。
公司是在香港成立的場外交易及金融科技發展協會的主要創始人一。集團參與協調和探索場外交易系統和金融技術的發展與方向。
鑑於近年來中華人民共和國鼓勵和促進區塊鏈技術的發展以及區塊鏈技術在金融證券領域的應用發展潛力,董事會認為,與區塊鏈技術相關的業務活動和研究的開展,將為集團創造更好的機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.